Medical Evidence & Clinical Frameworks for TRT
Guideline-based information to support informed conversations with a licensed clinician.
Slide 1 of 3
Clinical References
Guidelines and Regulatory Information
Endocrine Society: Testosterone Therapy in Men With Hypogonadism
Guidance on diagnosis, treatment selection, contraindications, and monitoring. Read the 2018 guideline.
American Urological Association: Testosterone Deficiency Guideline
Guidance on evaluation and management of testosterone deficiency (2018; validity confirmed 2024). Read the official guideline.
U.S. Food and Drug Administration: Testosterone Information
Current information on approved formulations and safety-labeling updates. Read FDA information.
Testosterone Therapy for Women: Global Consensus
The consensus limits the evidence-based indication to appropriately assessed postmenopausal women with HSDD and does not support general wellness claims. Read the consensus statement.
Comparing Testosterone Therapy Formulations
Testosterone is available in several formulations. No route is best for everyone; selection should be individualized based on the diagnosis, formulation-specific benefits and risks, fertility plans, patient preference, access, and monitoring needs.
Injectable testosterone
Injectable formulations use different routes and dosing intervals. Blood levels may rise and fall between doses, so the formulation, schedule, follow-up testing, symptoms, and adverse effects should guide any adjustment.
Transdermal gels, solutions, and patches
Transdermal products can avoid injections and are used on a product-specific schedule. Absorption and skin reactions vary, and some gels or solutions can transfer to another person unless prescribing-label precautions are followed.
Oral, nasal, and buccal products
FDA-approved oral, nasal, and buccal testosterone products exist for certain patients. Each has product-specific dosing, administration, interaction, and safety requirements; these routes should not be described as ineffective as a class.
Implants and compounded preparations
Implanted pellets provide longer-acting delivery but require a procedure and have formulation-specific risks. Compounded preparations are not FDA-approved and should not be presented as equivalent or superior to FDA-approved products; use requires a patient-specific clinical rationale and compliance with applicable law.